Recruiting Ulcerative Colitis Studies in Sun City
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisok...
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) compared with placebo in participants with moderately...
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
This is a Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate-to-severe UC. T...
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will comp...
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the safety and efficacy of AGN-193408 SR in participant...
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim...
About Ulcerative Colitis Clinical Trials in Sun City
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.
There are currently 6 ulcerative colitis clinical trials recruiting participants in Sun City, AZ. These studies are seeking a combined 1,961 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Hoffmann-La Roche, Sanofi and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ulcerative Colitis Clinical Trials in Sun City — FAQ
Are there ulcerative colitis clinical trials in Sun City?
Yes, there are 6 ulcerative colitis clinical trials currently recruiting in Sun City, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Sun City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you about next steps.
Are clinical trials in Sun City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sun City studies also compensate for your time and travel.
What ulcerative colitis treatments are being tested?
The 6 active trials in Sun City are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.
Data updated March 2, 2026 from ClinicalTrials.gov